Ming Yu Huang

US Patent:

20100318788, Dec 16, 2010

Filed:

Jun 12, 2009

Appl. No.:

12/483525

Inventors:

Alexandro Salvarani - Edison NJ, US
Ming Huang - Naperville IL, US
Harvey Rubin - Morristown NJ, US
Hsien-Chuen Yu - Naperville IL, US

International Classification:

H04L 9/32
H04L 9/30

US Classification:

713156, 380 30

Abstract:

An exemplary method of managing secure communications between nodes includes receiving a public key of a node associated with a certification authority. A root node certificate is provided to the node responsive to the received public key. The root node certificate indicates that the received public key belongs to the node. A root self-signed certificate corresponding to a public key of the certification authority is also provided to the node.

US Patent:

55342264, Jul 9, 1996

Filed:

Apr 19, 1995

Appl. No.:

8/424063

Inventors:

Michael Gavin - Warren NJ
Catherine M. Cimini - Somerset NJ
Ming Huang - Milltown NJ
Anthony Kuklo - Bridgewater NJ
James A. Mawhirt - Brooklyn NY
Eduardo Marcelino - Edison NJ

Assignee:

International Technidyne Corporation - Edison NJ

International Classification:

G01N 3386

US Classification:

422 73

Abstract:

A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined device of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing consol agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics. The normalized blood is tested simultaneously with the untreated blood to provide a reference value against which the functionality of the test system and the quality of the sample can be judged.

US Patent:

55914039, Jan 7, 1997

Filed:

Mar 18, 1996

Appl. No.:

8/617296

Inventors:

Michael Gavin - Warren NJ
Catherine M. Cimini - Somerset NJ
Ming Huang - Milltown NJ
Anthony Kuklo - Bridgewater NJ
James A. Mawhirt - Brooklyn NY
Eduardo Marcelino - Edison NJ
Albert Simone - Fords NJ

Assignee:

International Technidyne Corporation - Edison NJ

International Classification:

G01N 3386

US Classification:

422 73

Abstract:

A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined degree of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing control agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics. The normalized blood is tested simultaneously with the untreated blood to provide a reference value against which the functionality of the test system and the quality of the sample can be judged.

US Patent:

58007814, Sep 1, 1998

Filed:

Sep 25, 1996

Appl. No.:

8/719779

Inventors:

Michael Gavin - Warren NJ
Catherine M. Cimini - Somerset NJ
Ming Huang - Milltown NJ
Anthony Kuklo - Bridgewater NJ
James A. Mawhirt - Brooklyn NY
Eduardo Marcelino - Edison NJ
Albert Simone - Fords NJ

Assignee:

International Technidyne Corporation - Edison NJ

International Classification:

G01N 3386

US Classification:

422 73

Abstract:

A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined degree of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing control agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics. The normalized blood is tested simultaneously with the untreated blood to provide a reference value against which the functionality of the test system and the quality of the sample can be judged.

US Patent:

55040110, Apr 2, 1996

Filed:

Oct 21, 1994

Appl. No.:

8/327320

Inventors:

Michael Gavin - Warren NJ
Catherine M. Cimini - Somerset NJ
Ming Huang - Milltown NJ
Anthony Kuklo - Bridgewater NJ
James A. Mawhirt - Brooklyn NY
Eduardo Marcelino - Edison NJ
Albert Simone - Fords NJ

Assignee:

International Technidyne Corporation - Edison NY

International Classification:

G01N 3386

US Classification:

436 69

Abstract:

A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined degree of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing control agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics. The normalized blood is tested simultaneously with the untreated blood to provide a reference value against which the functionality of the test system and the quality of the sample can be judged.